The intracellular activity of ofloxacin and roxithromycin against Staphylococcus aureus phagocytosed in human neutrophils

CHEMOTHERAPY

Volumn 41, Issue 9, 1993, Pages 955-962

  Torigoe, Rikako ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Neutrophils; ofloxacin; roxithromycin; Staphylococcus aureus

Indexed keywords

LYSOSTAPHIN; OFLOXACIN; ROXITHROMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMPETIGO; INTRACELLULAR KILLING; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NORMAL HUMAN; PHAGOCYTOSIS; STAPHYLOCOCCUS AUREUS;

EID: 0027442242     PISSN: 00093165     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1953.41.955     Document Type: Article

References (24)

1. Rogers D E, Tompsett R: The survival of Staphylococci within human leukocytes. J Exp Med 95:209~235, 1952
2. Holmes B, Quie P G, Windhorst D B, Pollara B, Good R A: Protection of phagocytized bacteria from the killing action of antibiotics. Nature 210: 1131~1132, 1966
3. Prokesch R C, Hand W L: Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 21: 373~380, 1982
4. Hand W L, King-Thompson N L: Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity. Antimicrob Agents Chemother 29:135~140, 1986
5. Carlier M B, Zenebergh A, Tulkens P M:Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells. J Antimicrob Chemother 20, Suppl. B: 47~56, 1987
6. Hand W L, King-Thompson N, Holman J W: Entry of roxithromycin (RU 965), imipenem, cefotaxime, trimethoprim, and metronidazole into human polymorphonuclear leukocytes. Antimicrob Agents Chemother 31:1553~1557, 1987
7. Koga H: High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes. Antimicrob Agents Chemother 31:1904~1908, 1987
8. Ishiguro M, Koga H, Kohno S, Hayashi T, Yamaguchi K, Hirota M: Penetration of macrolides into human polymorphonuclear leucocytes. J Antimicrob Chemother 24: 719~729, 1989
9. Pascual A, Garcia I, Perea E J: Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes. Antimicrob Agents Chemother 33:653~656, 1989
10. Van der Auwera P, Prinz G, Petrikkos G: Activity of intracellular antibiotics. Infection 19 Suppl. 4: S216~S223, 1991
11. Anderson R, Van Rensburg C E J, Jooné G, Lukey P T: An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin. J Antimicrob Chemother 20 Suppl. B: 57~68, 1987
12. Pascual A, Martlnez-Martlnez L, Perea E J: Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against Staphylococci, Chemotherapy 35:17~22t 1989
13. van den Broek P J, Buys LFM, Aleman BMP: The antibacterial activity of benzylpenicillin against Staphylococcus aureus ingested by granulocytes. J Antimicrob Chemother 25:931~940, 1990
14. Vosbeck K, James P R, Zimmermann W: Antibiotic action on phagocytosed bacteria measured by a new method for determining viable bacteria. Antimicrob Agents Chemother 25:735~741, 1984
15. Amsterdam D: Susceptibility testing of antimicrobials in liquid media. In Antibiotics in Laboratory Medicine, 3rd edn. (Lorian V ed.), p.53~105. Williams & Wilkins, Baltimore, 1991
16. Boogaerts M A, Malbrain S, Scheers W, Ver-wilghen R L: Effects of quinolones on granulocyte function in vitro. Infection 14 Suppl. 4: S258~S262, 1986
17. Leijh P C J, van den Barselaar M T, Daha M R, van Furth R: Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Infect Immun 33: 714~724, 1980
18. Labro M T, Amit N, Babin-Chevaye C, Hakim J: Synergy between RU 28965 (Roxithromycin) and human neutrophils for bactericidal activity in vitro. Antimicrob Agents Chemother 30:137~ 142, 1986
19. Tan J S, Watanakunakorn C, Phair J P;A modified assay of neutrophil function: Use of lysostaphin to differentiate defective phagocytosis from impaired intracellular killing. J Lab Clin Med 78 (2): 316~322, 1971
20. van den Broek P J, Dehue FAM, Leijh P C J, van den Barselaar MTH, van Furth R: The use of lysostaphin in in vitro assays of phagocyte function: adherence to and penetration into granulocytes. Scand J Immunol 15:467~473, 1982
21. Pruzanski W, Saito S, Nitzan D W:The influence of lysostaphin on phagocytosis, intracellular bactericidal activity, and chemotaxis of human polymorphonuclear cells. J Lab Clin Med 102:298~305, 1983
22. Marmont A M, Damasio E, Zucker-Franklin D: Neutrophils. In Atlas of Blood Cells, 2nd edn. (Zucker-Franklin D, Greaves M F, Grossi C E, Marmont A M eds), p. 177, Lea & Febiger, Philadelphia, PA., 1988
23. Saito A et al.: Clinical studies on DL-8280. Chemotherapy (Tokyo) (in Japanese) 32 Suppl. 1: 225~238, 1984
24. Masaki M et al.: Laboratory and clinical studies on RU 28965. Chemotherapy (Tokyo) (in Japanese) 36:421~437, 1988